Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03293381 · ClinicalTrials.gov registry record
Electrogram-Guided Myocardial Advanced Phenotyping
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 35
- Enrollment target
NCT03293381: Clinical Trial study, sponsored by University of Pennsylvania.
NCT03293381 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03293381 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 35 participants
- Enrollment target
Study Summary
Fluoroscopy guided EMB and EAM guided EMB on all patients meeting existing guidelines for biopsy.
Primary Outcome
Additional biopsies
Interventions
- DEVICE additional biopsies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-11-30 |
| Est. Completion | 2024-11-30 |
Why NCT03293381 stopped before completion
NCT03293381 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which additional biopsies is the first listed.
NCT03293381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03293381 about?
NCT03293381 is a clinical study titled "Electrogram-Guided Myocardial Advanced Phenotyping". Fluoroscopy guided EMB and EAM guided EMB on all patients meeting existing guidelines for biopsy.
What is the current status of trial NCT03293381?
This trial is currently terminated. The enrollment target is 35 participants. The study started on 2018-11-30. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT03293381?
The interventions under investigation include: additional biopsies (DEVICE).
Who is sponsoring clinical trial NCT03293381?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI